Cargando…

Imaging in immune checkpoint inhibitor-induced polymyalgia rheumatica

Detalles Bibliográficos
Autores principales:	van der Geest, Kornelis S M, Sandovici, Maria, Rutgers, Abraham, Hiltermann, T Jeroen N, Oosting, Sjoukje F, Slart, Riemer H J A, Brouwer, Elisabeth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2022
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484368/ https://www.ncbi.nlm.nih.gov/pubmed/32241799 http://dx.doi.org/10.1136/annrheumdis-2020-217381

Ejemplares similares

Comparison and validation of FDG-PET/CT scores for polymyalgia rheumatica
por: van der Geest, Kornelis S M, et al.
Publicado: (2021)

Novel PET Imaging of Inflammatory Targets and Cells for the Diagnosis and Monitoring of Giant Cell Arteritis and Polymyalgia Rheumatica
por: van der Geest, Kornelis S. M., et al.
Publicado: (2022)

Leukocyte Dynamics Reveal a Persistent Myeloid Dominance in Giant Cell Arteritis and Polymyalgia Rheumatica
por: van Sleen, Yannick, et al.
Publicado: (2019)

Contribution of pathogenic T helper 1 and 17 cells to bursitis and tenosynovitis in polymyalgia rheumatica
por: Reitsema, Rosanne D., et al.
Publicado: (2022)

Humoral and cellular SARS-CoV-2 vaccine responses in patients with giant cell arteritis and polymyalgia rheumatica
por: van Sleen, Yannick, et al.
Publicado: (2022)

Aberrant phenotype of circulating antigen presenting cells in giant cell arteritis and polymyalgia rheumatica
por: Reitsema, Rosanne D., et al.
Publicado: (2023)

Back to the future: identification and classification of polymyalgia rheumatica and polymyalgia rheumatica-like syndromes following cancer immunotherapy with checkpoint inhibitors
por: Manzo, Ciro, et al.
Publicado: (2021)

Angiopoietin-2/-1 ratios and MMP-3 levels as an early warning sign for the presence of giant cell arteritis in patients with polymyalgia rheumatica
por: van Sleen, Yannick, et al.
Publicado: (2022)

Polymyalgia Rheumatica
por: Dixon, A. St J.
Publicado: (1969)

Polymyalgia rheumatica
por: Rosenberg, Hans, et al.
Publicado: (2021)

Diagnostic value of [18F]FDG-PET/CT in polymyalgia rheumatica: a systematic review and meta-analysis
por: van der Geest, K. S. M., et al.
Publicado: (2020)

Can SARS-CoV-2 trigger relapse of polymyalgia rheumatica?
por: Manzo, Ciro, et al.
Publicado: (2021)

An update on polymyalgia rheumatica
por: Lundberg, Ingrid E., et al.
Publicado: (2022)

Is Tocilizumab Effective and Safe in Polymyalgia Rheumatica and Giant-Cell Arteritis With Polymyalgia Rheumatica?
por: Farinango, Michelle, et al.
Publicado: (2022)

A Case of Clinical Uncertainty Solved: Giant Cell Arteritis with Polymyalgia Rheumatica Swiftly Diagnosed with Long Axial Field of View PET
por: Nienhuis, Pieter H., et al.
Publicado: (2022)

Polymyalgia rheumatica: an autoinflammatory disorder?
por: Floris, Alberto, et al.
Publicado: (2018)

Polymyalgia rheumatica: An update (Review)
por: Florescu, Mirela Marinela, et al.
Publicado: (2023)

FDG-PET/CT(A) imaging in large vessel vasculitis and polymyalgia rheumatica: joint procedural recommendation of the EANM, SNMMI, and the PET Interest Group (PIG), and endorsed by the ASNC
por: Slart, Riemer H. J. A.
Publicado: (2018)

Peripheral arterial disease in polymyalgia rheumatica
por: Borg, Frances A, et al.
Publicado: (2009)

Polymyalgia rheumatica in a married couple
por: Rüst, Christoph Alexander, et al.
Publicado: (2012)

A case report of polymyalgia rheumatica
por: Kniazkova, Iryna, et al.
Publicado: (2018)

Messages from the history of polymyalgia rheumatica
por: Manzo, Ciro
Publicado: (2021)

Tozinameran: Polymyalgia rheumatica: case report
Publicado: (2022)

Elasomeran: Polymyalgia rheumatica: case report
Publicado: (2022)

Tozinameran: Polymyalgia-rheumatica: case report
Publicado: (2022)

The association of pain and stiffness with fatigue in incident polymyalgia rheumatica: baseline results from the polymyalgia rheumatica cohort study
por: Prior, J.A., et al.
Publicado: (2019)

Polymyalgia rheumatica-like syndrome from checkpoint inhibitor therapy: case series and systematic review of the literature
por: Calabrese, Cassandra, et al.
Publicado: (2019)

Immune complex-mediated neutrophil activation in patients with polymyalgia rheumatica
por: Michailidou, Despina, et al.
Publicado: (2022)

The availability of health information to patients with newly diagnosed polymyalgia rheumatica: results from the Polymyalgia Rheumatica (PMR) Cohort study
por: Tshimologo, Maatla, et al.
Publicado: (2018)

Anterior Uveitis as an Initial Manifestation of Polymyalgia Rheumatica
por: Tsuda, Hiromasa, et al.
Publicado: (2011)

Metastatic Prostate Cancer Mimicking Polymyalgia Rheumatica
por: Randazzo, Charles T., et al.
Publicado: (2011)

Polymyalgia rheumatica as the first presentation of parathyroid carcinoma
por: Unubol, Mustafa, et al.
Publicado: (2013)

Successful treatment with clarithromycin for patients with polymyalgia rheumatica
por: Ohe, Masashi, et al.
Publicado: (2014)

Relapse of polymyalgia rheumatica after a fall
por: Manzo, Ciro, et al.
Publicado: (2017)

Comorbidities in polymyalgia rheumatica: a systematic review
por: Partington, Richard, et al.
Publicado: (2018)

Sternoclavicular Joint Hypertrophy Involved in Polymyalgia Rheumatica
por: Yamamoto, Koichiro, et al.
Publicado: (2021)

Polymyalgia Rheumatica in a Patient with Pseudogout and Dementia
por: Aoki, Nozomi, et al.
Publicado: (2021)

Polymyalgia Rheumatica Following COVID-19 Vaccination
por: Yokote, Akira, et al.
Publicado: (2022)

SARS-CoV-2, polymyalgia rheumatica and giant cell arteritis: COVID-19 vaccine shot as a trigger? Comment on: “Can SARS-CoV-2 trigger relapse of polymyalgia rheumatica?” by Manzo et al. Joint Bone Spine 2021;88:105150
por: Cadiou, Simon, et al.
Publicado: (2022)

Efficacy of JAK Inhibitors versus DMARDs in the Treatment of Polymyalgia Rheumatica in China
por: Gu, Juanfang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kvv4rklecspbmk1rceu7rf9iem